TEPLUME

Details for Australian Trade Mark No. 1355651 (hide)

Owner MacroGenics, Inc. a Delaware corporation

Convention US 9 October 2009 77/845742

Service Spruson & Ferguson

Filing Date 8 April 2010

Classes

Class 5 Pharmaceutical preparations for use in the treatment of diabetes; pharmaceutical preparations for use in the treatment of rheumatoid arthritis; pharmaceutical preparations for use in the treatment of Crohn's disease; pharmaceutical preparations for use in the treatment of psoriasis; pharmaceutical preparations for use in the treatment of autoimmune disorders; pharmaceutical preparations for use in the treatment of cancer

Event Publications

29 April 2010 Application filed

13 May 2010 Application Accepted

9 September 2010 Trade Mark Registered/Protected

25 August 2011 Subsequent Owners/Holder Registered - Full Assignment

  MacroGenics, Inc. a Delaware corporation is the full asignee of Eli Lilly and Company incorporated in the State of Indiana.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1355652-TEPEXUS

1355650-EUTEPIA